By G HossainPosted on February 4, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Mounjaro and Zepbound combined for $11.7 billion in the fourth quarter, which beat analyst consensus of $10.6 billion. Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue up 46% in Q4 Post navigation Novartis Sticks With M&A Strategy of Building Early Pipeline, Searching for Near-LaunchesGSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity